ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Recipient Outcomes of DCD Kidneys with and without Donor TPA Administration

E. Shipman, W. De Faria, L. Preczewski, R. Vianna, G. Guerra

Miami Transplant Institute, Miami, FL

Meeting: 2020 American Transplant Congress

Abstract number: A-235

Keywords: Cadaveric organs, Donation, Kidney/liver transplantation, Renal thrombosis

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session A: Deceased Donor Management and Intervention Research

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Use of Tissue Plasminogen Activator (TPA) in Liver Transplantation from Donation After Cardiac Death (DCD) Donors: A Controlled Randomized Trial
  • Transplant Outcomes of DCD Kidneys Recovered with vs. without Pre-Recovery Heparin Administration

*Purpose: Our OPO utilizes a TPA administration protocol for DCD liver donors to be transplanted at our center. This results in a series of DCD kidneys also transplanted at our center, some of which (livers placed at our center) were from DCD donors given TPA after death and others of which (livers allocated to another center or discarded) were from DCD donors not given TPA. We reviewed these transplants to identify whether donor TPA administration affected outcomes.

*Methods: We retrospectively analyzed 53 consecutive transplants of local DCD kidneys transplanted between 10/2016 and 03/2019 at our center. Primary endpoints were eGFR by MDRD equation at 1-year post-tx and incidence of post-op hematoma. 43 patients survived with function and f/u at 1 year. Patient and death-censored graft Kaplan-Meier survival curves were compared by Cox Proportional Hazards Model. Means of risk factors known to impact 1-year eGFR at our center were compared with a t-test. Rates of surgical complications were assessed with Fisher’s Exact Test.

*Results: The groups were not significantly different in KDPI, cold ischemic time, final resistance on pump, or % glomerulosclerosis. Of note, while none of these differences were significant, all 4 known risk factors had higher values in the non-TPA group.

Donor TPA No Donor TPA p-value (t-test)
n 24 19
KDPI 56.1 58.6 NS
CIT 25.6 29.4 NS
Final Pump Resistance .192 .217 NS
Glomerulosclerosis % 4.14 7.54 NS

Patient and death-censored graft survival curves were not statistically different. Recipients of DCD kidneys from donors given TPA had a mean one-year post-transplant eGFR of 62.7 [SD: 19.7] compared with recipients of DCD kidneys from donors not given TPA who had a mean one-year post-transplant eGFR of 54.9 [SD 18.4]. This difference (figure 1) was not significant (p=0.1943). The incidence of post-transplant hematomas documented as a surgical complication was 14.3% in the TPA group vs 0% in the non-TPA group (p=NS).

*Conclusions: The use of TPA in DCD donors did not appear to adversely impact outcomes of recipients. Of note, the samples were not fully randomized, as donors not suitable for placement of the liver all were in the non-TPA group. The incidence of hematomas, while not significant, warrants further study in a larger sample

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Shipman E, Faria WDe, Preczewski L, Vianna R, Guerra G. Recipient Outcomes of DCD Kidneys with and without Donor TPA Administration [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/recipient-outcomes-of-dcd-kidneys-with-and-without-donor-tpa-administration/. Accessed April 22, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.